Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Isbarn

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
The Journal of Urology|June 19, 2009
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasiaClaudio Jeldres, Hendrik Isbarn, Umberto Capitanio, et al.
Archivos Espanoles De Urologia|May 8, 2015
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended samplingHendrik Isbarn, Alberto Briganti, Pieter J L De Visschere, et al.
Urologic Oncology|September 21, 2014
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical reviewCristian I Surcel, Inge M van Oort, Prasanna Sooriakumaran, et al.
Journal of Endourology|July 14, 2009
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapyHendrik Isbarn, Claudio Jeldres, Umberto Capitanio, et al.
The Journal of Urology|November 17, 2009
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancerShahrokh F Shariat, Daher C Chade, Pierre I Karakiewicz, et al.
Insights Into Imaging|February 6, 2016
Role of multiparametric magnetic resonance imaging in early detection of prostate cancerPieter J L De Visschere, Alberto Briganti, Jurgen J Fütterer, et al.
Urologic Oncology|August 19, 2014
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patientsGuillaume Ploussard, Hendrik Isbarn, Alberto Briganti, et al.
The Journal of Urology|December 20, 2011
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkersShahrokh F Shariat, Thomas F Chromecki, Eugene K Cha, et al.
BJU International|May 8, 2014
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based surveyCristian I Surcel, Prasanna Sooriakumaran, Alberto Briganti, et al.
Urologic Oncology|January 27, 2015
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional seriesGiorgio Gandaglia, Guillaume Ploussard, Hendrik Isbarn, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
The Journal of Urology|June 19, 2009
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasiaClaudio Jeldres, Hendrik Isbarn, Umberto Capitanio, et al.
Archivos Espanoles De Urologia|May 8, 2015
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended samplingHendrik Isbarn, Alberto Briganti, Pieter J L De Visschere, et al.
Urologic Oncology|September 21, 2014
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical reviewCristian I Surcel, Inge M van Oort, Prasanna Sooriakumaran, et al.
Journal of Endourology|July 14, 2009
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapyHendrik Isbarn, Claudio Jeldres, Umberto Capitanio, et al.
The Journal of Urology|November 17, 2009
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancerShahrokh F Shariat, Daher C Chade, Pierre I Karakiewicz, et al.
Insights Into Imaging|February 6, 2016
Role of multiparametric magnetic resonance imaging in early detection of prostate cancerPieter J L De Visschere, Alberto Briganti, Jurgen J Fütterer, et al.
Urologic Oncology|August 19, 2014
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patientsGuillaume Ploussard, Hendrik Isbarn, Alberto Briganti, et al.
The Journal of Urology|December 20, 2011
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkersShahrokh F Shariat, Thomas F Chromecki, Eugene K Cha, et al.
BJU International|May 8, 2014
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based surveyCristian I Surcel, Prasanna Sooriakumaran, Alberto Briganti, et al.
Urologic Oncology|January 27, 2015
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional seriesGiorgio Gandaglia, Guillaume Ploussard, Hendrik Isbarn, et al.
Pageof 14